Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MSMB antibody

The Mouse Monoclonal anti-MSMB antibody has been validated for WB, IHC and IF. It is suitable to detect MSMB in samples from Human. There is 1 publication available.
Catalog No. ABIN2726441

Quick Overview for MSMB antibody (ABIN2726441)

Target

See all MSMB Antibodies
MSMB (Microseminoprotein, beta (MSMB))

Reactivity

  • 38
  • 8
  • 4
  • 1
Human

Host

  • 32
  • 7
  • 1
Mouse

Clonality

  • 32
  • 8
Monoclonal

Conjugate

  • 23
  • 6
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MSMB antibody is un-conjugated

Application

  • 28
  • 13
  • 12
  • 7
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Clone

6C7
  • Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogen

    Full length human recombinant protein of human MSMB (NP_002434) produced in HEK293T cell.

    Isotype

    IgG1
  • Application Notes

    WB 1:2000, IHC 1:50, IF 1:100,

    Comment

    The concentration of the product may vary between diferrent lots.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5-1.0 mg/mL

    Buffer

    PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Bergström, Järemo, Nilsson, Adamo, Bergh: "Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness." in: The Prostate, Vol. 78, Issue 4, pp. 257-265, (2019) (PubMed).

  • Target

    MSMB (Microseminoprotein, beta (MSMB))

    Alternative Name

    MSMB

    Molecular Weight

    10.7kDa

    Gene ID

    4477

    NCBI Accession

    NM_002443

    HGNC

    4477
You are here:
Chat with us!